Penn Capital Management’s NeoGenomics NEO Stock Holding History

Penn Capital Management’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-85,813	Closed	-$1.32M	–	272
2018 Q3	$1.32M	Sell	85,813 -66,753	-44%	-$923K	0.1%	197
2018 Q2	$2M	Sell	152,566 -136,859	-47%	-$1.51M	0.15%	162
2018 Q1	$2.36M	Sell	289,425 -84,200	-23%	-$682K	0.19%	146
2017 Q4	$3.31M	Sell	373,625 -33,534	-8%	-$309K	0.23%	119
2017 Q3	$4.53M	Buy	407,159 +127,903	+46%	+$1.24M	0.33%	99
2017 Q2	$2.5M	Buy	+279,256	New	+$2.22M	0.19%	133

Other funds holding NEO

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

ECM

Element Capital Management New York $3.2B AUM 29.54% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

CTA

Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return

Penn Capital Management's NEO Position: Q4 2018 in Review

Penn Capital Management sold out of NeoGenomics (NEO) in Q4 2018, closing a stake of 85,813 shares — an estimated $1.32M sold.

Penn Capital Management first reported a position in NEO in Q2 2017 and held it in 6 quarters. The position peaked at $4.53M in Q3 2017. 210 funds tracked by Wall St. Rank hold NEO as of Q4 2018.

Penn Capital Management reported no remaining NeoGenomics position as of Q4 2018 after selling out during the quarter.
Penn Capital Management sold 85,813 NeoGenomics shares in Q4 2018, an estimated $1.32M.
Penn Capital Management first reported a position in NeoGenomics in Q2 2017 and held it in 6 quarters.
Penn Capital Management's NeoGenomics position peaked at $4.53M in Q3 2017.
210 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2018.

Based on Penn Capital Management's 13F filing for Q4 2018, filed 19 Feb 2019.